Subscribe To
What's going on with dyne therapeutics shares today?
Dyne Therapeutics Inc (NASDAQ: DYN) shares are trading lower by 5.42% to $6.81 after the company announced fd...
July 5, 2022, 10:24 am
Cutera: the 'aviclear' sign to get bullish
Cutera has received an fda clearance for the first and only laser-based acne treatment representing a s...
June 21, 2022, 9:20 pm
Aerc stock is in the spotlight after aeroclean receives fda clearance
Yesterday, the FDA designated AeroClean's air purification system as a "Class II Medical Device," this sent AERC stock soaring. The post AERC Stock I...
June 7, 2022, 10:42 am
Merit medical's (mmsi) scout bx delivery system gets fda nod
Merit Medical's (MMSI) receipt of fda clearance for the SCOUT Bx system can streamline treatment for ca...
April 12, 2022, 12:02 pm
Fitbit gets fda clearance for afib detection feature
Google says the technology is coming soon....
April 11, 2022, 11:58 am
Prothena (prta) ind application gets fda clearance for ad
Prothena (PRTA) application for evaluating PRX012 for the treatment of Alzheimer's disease (AD) gets fda clear...
March 29, 2022, 12:48 pm
Moderna seeks fda clearance for second covid-19 booster shot in all adults
Moderna's request is broader than one submitted by Pfizer and BioNTech earlier this week....
March 18, 2022, 3:42 am
Masimo's (masi) sedline receives fda's pediatric indication
The latest fda clearance for Masimo's (MASI) SedLine is likely to improve brain function monitoring in ...
March 2, 2022, 12:14 pm
Masimo's (masi) sedline receives fda's pediatric indication
The latest fda clearance for Masimo's (MASI) SedLine is likely to improve brain function monitoring in ...
March 2, 2022, 12:14 pm
Masimo's (masi) sedline receives fda's pediatric indication
The latest fda clearance for Masimo's (MASI) SedLine is likely to improve brain function monitoring in ...
March 2, 2022, 12:14 pm
Tandem diabetes (tndm) to offer insulin delivery with smartphone
Tandem Diabetes' (TNDM) t:connect is the first-ever app on both iOS and Android operating systems to receive f...
February 17, 2022, 10:47 am
Tandem diabetes (tndm) to offer insulin delivery with smartphone
Tandem Diabetes' (TNDM) t:connect is the first-ever app on both iOS and Android operating systems to receive f...
February 17, 2022, 10:47 am
Tandem diabetes (tndm) to offer insulin delivery with smartphone
Tandem Diabetes' (TNDM) t:connect is the first-ever app on both iOS and Android operating systems to receive f...
February 17, 2022, 10:47 am
Nuvation (nuvb) gets fda clearance for oncology candidate
Nuvation (NUVB) will be initiating a phase I/II study of NUV-868 as a monotherapy and in combination with Lynparza or Xtandi in multiple tumor types f...
January 21, 2022, 11:35 am
Nuvation (nuvb) gets fda clearance for oncology candidate
Nuvation (NUVB) will be initiating a phase I/II study of NUV-868 as a monotherapy and in combination with Lynparza or Xtandi in multiple tumor types f...
January 21, 2022, 11:35 am
Nuvation (nuvb) gets fda clearance for oncology candidate
Nuvation (NUVB) will be initiating a phase I/II study of NUV-868 as a monotherapy and in combination with Lynparza or Xtandi in multiple tumor types f...
January 21, 2022, 11:35 am
4d molecular therapeutics announces fda clearance of ind application for 4d-150, a dual-transgene intravitreal gene therapy for patients with wet amd
Initiation of 4D-150 Phase 1/2 clinical trial sites expected before year-end Initiation of 4D-150 Phase 1/2 clinical trial sites expected before year-...
October 6, 2021, 7:30 am
4d molecular therapeutics announces fda clearance of ind application for 4d-150, a dual-transgene intravitreal gene therapy for patients with wet amd
Initiation of 4D-150 Phase 1/2 clinical trial sites expected before year-end Initiation of 4D-150 Phase 1/2 clinical trial sites expected before year-...
October 6, 2021, 7:30 am
4d molecular therapeutics announces fda clearance of ind application for 4d-150, a dual-transgene intravitreal gene therapy for patients with wet amd
Initiation of 4D-150 Phase 1/2 clinical trial sites expected before year-end Initiation of 4D-150 Phase 1/2 clinical trial sites expected before year-...
October 6, 2021, 7:30 am